CS260497B1 - New amides of lysergic acid and methods of their production as well as therapeutical means containing these compounds - Google Patents

New amides of lysergic acid and methods of their production as well as therapeutical means containing these compounds Download PDF

Info

Publication number
CS260497B1
CS260497B1 CS864066A CS406686A CS260497B1 CS 260497 B1 CS260497 B1 CS 260497B1 CS 864066 A CS864066 A CS 864066A CS 406686 A CS406686 A CS 406686A CS 260497 B1 CS260497 B1 CS 260497B1
Authority
CS
Czechoslovakia
Prior art keywords
acid
formula
dihydrolysergic
compounds
amide
Prior art date
Application number
CS864066A
Other languages
Czech (cs)
English (en)
Other versions
CS406686A1 (en
Inventor
Roland Hempel
Karlheinz Heidenbluth
Christoph Dauth
Joachim Schmidt
Reni Bartsch
Angelika Rostock
Wolfgang Hoffmann
Evelyn Morgenstern
Erika Glusa
Werner Grawert
Original Assignee
Roland Hempel
Karlheinz Heidenbluth
Christoph Dauth
Joachim Schmidt
Reni Bartsch
Angelika Rostock
Wolfgang Hoffmann
Evelyn Morgenstern
Erika Glusa
Werner Grawert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roland Hempel, Karlheinz Heidenbluth, Christoph Dauth, Joachim Schmidt, Reni Bartsch, Angelika Rostock, Wolfgang Hoffmann, Evelyn Morgenstern, Erika Glusa, Werner Grawert filed Critical Roland Hempel
Publication of CS406686A1 publication Critical patent/CS406686A1/cs
Publication of CS260497B1 publication Critical patent/CS260497B1/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CS864066A 1985-06-10 1986-06-03 New amides of lysergic acid and methods of their production as well as therapeutical means containing these compounds CS260497B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD27717585A DD238051A1 (de) 1985-06-10 1985-06-10 Verfahren zur herstellung neuer lysergsaeureamide

Publications (2)

Publication Number Publication Date
CS406686A1 CS406686A1 (en) 1988-05-16
CS260497B1 true CS260497B1 (en) 1988-12-15

Family

ID=5568455

Family Applications (1)

Application Number Title Priority Date Filing Date
CS864066A CS260497B1 (en) 1985-06-10 1986-06-03 New amides of lysergic acid and methods of their production as well as therapeutical means containing these compounds

Country Status (9)

Country Link
EP (1) EP0205068B1 (US06589383-20030708-C00041.png)
BG (1) BG44609A1 (US06589383-20030708-C00041.png)
CS (1) CS260497B1 (US06589383-20030708-C00041.png)
DD (1) DD238051A1 (US06589383-20030708-C00041.png)
DE (1) DE3683190D1 (US06589383-20030708-C00041.png)
HU (1) HU196398B (US06589383-20030708-C00041.png)
PL (1) PL149497B1 (US06589383-20030708-C00041.png)
RO (1) RO94160B (US06589383-20030708-C00041.png)
SU (1) SU1481233A1 (US06589383-20030708-C00041.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023039682A1 (en) * 2021-09-20 2023-03-23 Betterlife Pharma Inc. Lsd derivatives, synthesis & method for treatment of diseases and disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239530A (en) * 1964-01-13 1966-03-08 Sandoz Ltd Process for lysergic acid hydrazides
HU169073B (US06589383-20030708-C00041.png) * 1974-05-28 1976-09-28
DD146460A1 (de) * 1979-11-14 1981-02-11 Reni Bartsch Verfahren zur herstellung 1-benzylierter ergometrinderivate
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen

Also Published As

Publication number Publication date
BG44609A1 (US06589383-20030708-C00041.png) 1989-01-16
RO94160A (ro) 1988-03-30
SU1481233A1 (ru) 1989-05-23
EP0205068A2 (de) 1986-12-17
CS406686A1 (en) 1988-05-16
EP0205068A3 (en) 1988-01-13
PL149497B1 (en) 1990-02-28
HUT43038A (en) 1987-09-28
DE3683190D1 (de) 1992-02-13
DD238051A1 (de) 1986-08-06
EP0205068B1 (de) 1992-01-02
RO94160B (ro) 1988-03-31
HU196398B (en) 1988-11-28

Similar Documents

Publication Publication Date Title
Clarke et al. Compounds affecting the central nervous system. 4. 3. beta.-phenyltropane-2-carboxylic esters and analogs
EP0165904B1 (de) Substituierte bicyclische Verbindungen
Thompson et al. Synthesis and pharmacological evaluation of a series of dibenzo [a, d] cycloalkenimines as N-methyl-D-aspartate antagonists
CZ26396A3 (en) Novel perhydroisoindole derivatives, process of their preparation and pharmaceutical compositions containing thereof
Kohn et al. Preparation and anticonvulsant activity of a series of functionalized. alpha.-heteroatom-substituted amino acids
US6365585B1 (en) Phosphodiesterase IV-inhibiting diazepinoindoles
DE4243287A1 (de) N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
JPH05194511A (ja) ピラゾール環がアルキル化されたピラゾロキノリン類
EP0189370A2 (de) Spiro-dioxolane, -dithiolane und -oxothiolane
CZ279745B6 (cs) Stereochemicky čistý derivát 2-hydroxycyklopentylamidu ergolinu, jeho použití, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
FR2593818A1 (fr) Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
EP0155903B1 (de) Indolophenanthridine, ihre Herstellung und Verwendung
DE3587556T2 (de) 2-Substituierte Aminomethyl-1,4-benzodiazepine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
JPH02111776A (ja) 四環式抗うつ剤
DK143105B (da) Analogifremgangsmaade til fremstilling af aminobenzocycloheptf enderivater eller farmaceutisk acceptable additionssalte dera
CS260497B1 (en) New amides of lysergic acid and methods of their production as well as therapeutical means containing these compounds
KOJIMA et al. Syntheses of (±)-2-[(inden-7-yloxy) methyl] morpholine hydrochloride (YM-08054, indeloxazine hydrochloride) and its derivatives with potential cerebral-activating and antidepressive properties
EP0338989B1 (en) Heterotetracyclic lactam derivatives, process for their preparation, and pharmaceutical compositions containing them
FI71320B (fi) Foerfarande foer framstaellning av nya antiarytmiska etrar ochestrar av 3,7-diazabicyklo/3.3.1/nonan-9-oler
DE2305514A1 (de) Verfahren zur herstellung von lysergsaeureamiden und dihydrolysergsaeureamiden sowie lysergsaeureamide und dihydrolysergsaeureamide und ihre verwendung
SU1440347A3 (ru) Способ получени производных 9-или 11-нитроаповинкаминовой кислоты или их солей
US4539402A (en) Quinazolinone derivatives
OHSAKI et al. Synthesis of Imidazo [4, 5-e][1, 4] diazepine and Imidazo [4, 5-e][1, 4]-oxazepine Derivatives Using Caffeidine, a Hydrolysis Product of Caffeine
FI84723B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-(1,8-naftyridin-2-yl)-isoindolin-1-oner.
JPH06509799A (ja) Cns活性のテトラヒドロベンゾチエノピリジン類